Chinese medical device maker Hanyu closes $72m in Series D round

Source: National Cancer Institute/Unsplash

Hanyu Medical, a Chinese startup that develops heart valve interventional medical devices, has garnered 500 million yuan ($72 million) in its Series D round to promote the premarket clinical trials of what could be China’s first domestically developed mitral valve repair product.

The Series D round was jointly led by Chinese healthcare-focused fund Highlight Capital, CITIC’s alternative asset management arm CPE, and Shanghai-based Yingke PE, a mixed-ownership investment major backed by large-scale financial institutions and state-owned companies.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter